Kevin Weil, formerly OpenAI's science lead, launches Warp Sciences, an AI startup training robots to synthesize and test drug compounds. Weil says the company raised $215 million at an $865 million valuation, led by Lightspeed. He aims to reshore lab work now outsourced to Chinese contractors such as WuXi AppTec.
Radical Numerics says phages designed by its Omnii-1 genome language model have been given to a patient with an antibiotic-resistant infection under a physician-led compassionate-use pathway, which the company calls the first clinical use of AI-generated phages. The company reports the cocktail cleared the patient's isolate in vitro but did not disclose outcomes.
OpenAI acquired Orchestra Bio, a four-year-old startup whose AI agents handle drug-discovery operations such as clinical trial scheduling and finances. Terms were not disclosed; Orchestra had raised about $20 million. OpenAI says it will fold the team and technology into Rosalind, its life sciences model, and Rosalind Workbench, which it says Moderna and Novo Nordisk use.
Google says its AI models help scientists diagnose genetic disease in under eight hours and repurpose existing drugs. Researchers at Barcelona's Institute for Global Health used AlphaFold to screen 30,000 compounds against Chagas disease, flagging two FDA-approved candidates. Google.org reports giving over $60 million in 2026.
Basecamp Research raises a $140 million Series C to train AI models for designing therapeutics, beginning with in vivo cell therapy, in a round led by S32 with Nvidia’s NVentures and Anthropic’s Anthology Fund participating.
Novo Nordisk partners with Anthropic to accelerate drug development with AI as CEO Mike Doustdar pushes to make the company the world’s most AI-driven healthcare business amid fierce obesity-market competition.
An unidentified AI model called Ox Alpha stuns the tech world with frontier-level coding power and no known creator, while Lady Gaga's startup unveils living skin tech that slashes skincare discovery timelines, and Google's Gemini Canvas transforms spreadsheet data into shareable interactive dashboards instantly.
AI agents are transforming industries at record speed, with Anthropic's Claude crushing drug design benchmarks at up to 35% success rates, Uber slashing two-day financial reports to 10 minutes using lean AI pods, and Replit scaling usage 30x by offering free access to powerful AI models.
Former OpenAI executive Fidji Simo launches ChronicleBio, an AI-powered startup using home blood draws and 153 terabytes of biological data to identify chronic disease sub-groups and improve clinical drug trial success rates.
A consortium of AI companies including Loka, AWS, and Arcee AI releases Trinity Mini, an open 26-billion-parameter biomedical reasoning model trained with reinforcement learning that achieves 81.2% drug evaluation accuracy, offering organizations an auditable, deployable solution for specialized scientific AI within controlled infrastructure.